|
1
|
Bianchini G, Balko JM, Mayer IA, Sanders
ME and Gianni L: Triple-negative breast cancer: Challenges and
opportunities of a heterogeneous disease. Nat Rev Clin Oncol.
13:674–690. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mustacchi G and De Laurentiis M: The role
of taxanes in triple-negative breast cancer: Literature review.
Drug Des Devel Ther. 9:4303–4318. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang N, Wang C, Wang J, Wang Z, Huang D,
Yan M, Kamran M, Liu Q and Xu B: Aurora kinase A stabilizes FOXM1
to enhance paclitaxel resistance in triple-negative breast cancer.
J Cell Mol Med. 23:6442–6453. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lock R, Kenific CM, Leidal AM, Salas E and
Debnath J: Autophagy-dependent production of secreted factors
facilitates oncogenic RAS-driven invasion. Cancer Discov.
4:466–479. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu CC, Chan ML, Chen WY, Tsai CY, Chang FR
and Wu YC: Pristimerin induces caspase-dependent apoptosis in
MDA-MB-231 cells via direct effects on mitochondria. Mol Cancer
Ther. 4:1277–1285. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu Q, Wu W, Fu B, Shi L, Wang X and Kuca
K: JNK signaling in cancer cell survival. Med Res Rev.
39:2082–2104. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xing YQ, Li A, Yang Y, Li XX, Zhang LN and
Guo HC: The regulation of FOXO1 and its role in disease
progression. Life Sci. 193:124–131. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cheon SY, Kim H, Rubinsztein DC and Lee
JE: Autophagy, cellular aging and age-related human diseases. Exp
Neurobiol. 28:643–647. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tompkins KD and Thorburn A: Regulation of
apoptosis by autophagy to enhance cancer therapy. Yale J Biol Med.
92:707–718. 2019.PubMed/NCBI
|
|
10
|
Jing Z, Sui X, Yao J, Xie J, Jiang L, Zhou
Y, Pan H and Han W: SKF-96365 activates cytoprotective autophagy to
delay apoptosis in colorectal cancer cells through inhibition of
the calcium/CaMKIIγ/AKT-mediated pathway. Cancer Lett. 372:226–238.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng H, Cheng X, Kuang J, Chen L, Yuen S,
Shi M, Liang J, Shen B, Jin Z, Yan J and Qiu W: Apatinib-induced
protective autophagy and apoptosis through the AKT-mTOR pathway in
anaplastic thyroid cancer. Cell Death Dis. 9:10302018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xi G, Hu X, Wu B, Jiang H, Young CYF, Pang
Y and Yuan H: Autophagy inhibition promotes paclitaxel-induced
apoptosis in cancer cells. Cancer Lett. 307:141–148. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang SF, Wang XY, Fu ZQ, Peng QH, Zhang
JY, Ye F, Fu YF, Zhou CY, Lu WG, Cheng XD and Xie X: TXNDC17
promotes paclitaxel resistance via inducing autophagy in ovarian
cancer. Autophagy. 11:225–238. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nagata S: Apoptosis and clearance of
apoptotic cells. Annu Rev Immunol. 36:489–517. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mohammed F, Rashid-Doubell F, Taha S,
Cassidy S and Fredericks S: Effects of curcumin complexes on
MDA-MB-231 breast cancer cell proliferation. Int J Oncol.
57:445–455. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiao D, Cheng W, Zhang X, Zhang Y, Guo J,
Li Z, Shi D, Xiong Z, Qing Y, Jamal MA, et al: Improving porcine
SCNT efficiency by selecting donor cells size. Cell Cycle.
20:2264–2277. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu W, Qu H, Xu K, Jia B, Li H, Du Y, Liu
G, Wei HJ and Zhao HY: Differences in the starvation-induced
autophagy response in MDA-MB-231 and MCF-7 breast cancer cells.
Anim Cells Syst (Seoul). 21:190–198. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lv C, Qu H, Zhu W, Xu K, Xu A, Jia B, Qing
Y, Li H, Wei HJ and Zhao HY: Low-dose paclitaxel inhibits tumor
cell growth by regulating glutaminolysis in colorectal carcinoma
cells. Front Pharmacol. 8:2442017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mekhail TM and Markman M: Paclitaxel in
cancer therapy. Expert Opin Pharmacother. 3:755–766. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Alers S, Loffler AS, Wesselborg S and
Stork B: Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy:
Cross talk, shortcuts, and feedbacks. Mol Cell Biol. 32:2–11. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Levy JMM, Towers CG and Thorburn A:
Targeting autophagy in cancer. Nat Rev Cancer. 17:528–542. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Onorati AV, Dyczynski M, Ojha R and
Amaravadi RK: Targeting autophagy in cancer. Cancer. 124:3307–3318.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Füllgrabe J, Ghislat G, Cho DH and
Rubinsztein DC: Transcriptional regulation of mammalian autophagy
at a glance. J Cell Sci. 129:3059–3066. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Weaver BA: How taxol/paclitaxel kills
cancer cells. Mol Biol Cell. 25:2677–2681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Orr GA, Verdier-Pinard P, McDaid H and
Horwitz SB: Mechanisms of taxol resistance related to microtubules.
Oncogene. 22:7280–7295. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yusuf R, Duan Z, Lamendola D, Penson R and
Seiden M: Paclitaxel resistance: Molecular mechanisms and
pharmacologic manipulation. Curr Cancer Drug Targets. 3:1–19. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Blanchard Z, Paul BT, Craft B and ElShamy
WM: BRCA1-IRIS inactivation overcomes paclitaxel resistance in
triple negative breast cancers. Breast Cancer Res. 17:52015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bhola NE, Balko JM, Dugger TC, Kuba MG,
Sánchez V, Sanders M, Stanford J, Cook RS and Arteaga CL: TGF-β
inhibition enhances chemotherapy action against triple-negative
breast cancer. J Clin Invest. 123:1348–1358. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wee ZN, Yatim SMJ, Kohlbauer VK, Feng M,
Goh JY, Bao Y, Lee PL, Zhang S, Wang PP, Lim E, et al: IRAK1 is a
therapeutic target that drives breast cancer metastasis and
resistance to paclitaxel. Nat Commun. 6:87462015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sha L, Zhang Y, Wang W, Sui X, Liu SK,
Wang T and Zhang H: MiR-18a upregulation decreases dicer expression
and confers paclitaxel resistance in triple negative breast cancer.
Eur Rev Med Pharmacol Sci. 20:2201–2208. 2016.PubMed/NCBI
|
|
32
|
Yuan Z, Jiang H, Zhu X, Liu X and Li J:
Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through
inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on
triple-negative breast cancer. Biomed Pharmacother. 89:227–232.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou YF, Sun Q, Zhang YJ, Wang GM, He B,
Qi T, Zhou Y, Li XW, Li S and He L: Targeted inhibition of notch1
gene enhances the killing effects of paclitaxel on triple negative
breast cancer cells. Asian Pac J Trop Med. 10:179–183. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wen J, Yeo S, Wang C, Chen S, Sun S, Haas
MA, Tu W, Jin F and Guan JL: Autophagy inhibition re-sensitizes
pulse stimulation-selected paclitaxel-resistant triple negative
breast cancer cells to chemotherapy-induced apoptosis. Breast
Cancer Res Treat. 149:619–629. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sui X, Chen R, Wang Z, Huang Z, Kong N,
Zhang M, Han W, Lou F, Yang J, Zhang Q, et al: Autophagy and
chemotherapy resistance: A promising therapeutic target for cancer
treatment. Cell Death Dis. 4:e8382013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang K: Autophagy and apoptosis in liver
injury. Cell Cycle. 14:1631–1642. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Veldhoen R, Banman S, Hemmerling D, Odsen
R, Simmen T, Simmonds AJ, Underhill DA and Goping IS: The
chemotherapeutic agent paclitaxel inhibits autophagy through two
distinct mechanisms that regulate apoptosis. Oncogene. 32:736–746.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xie S, Ogden A, Aneja R and Zhou J:
Microtubule-binding proteins as promising biomarkers of paclitaxel
sensitivity in cancer chemotherapy. Med Res Rev. 36:300–312. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Eum KH and Lee M: Crosstalk between
autophagy and apoptosis in the regulation of paclitaxel-induced
cell death in v-Ha-ras-transformed fibroblasts. Mol Cell Biochem.
348:61–68. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhou J, Liao W, Yang J, Ma K, Li X, Wang
Y, Wang D, Wang L, Zhang Y, Yin Y, et al: FOXO3 induces
FOXO1-dependent autophagy by activating the AKT1 signaling pathway.
Autophagy. 8:1712–1723. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xu P, Das M, Reilly J and Davi RJ: JNK
regulates FoxO-dependent autophagy in neurons. Genes Dev.
25:310–322. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhao Y, Yang J, Liao W, Liu X, Zhang H,
Wang S, Wang D, Feng J, Yu L and Zhu WG: Cytosolic FoxO1 is
essential for the induction of autophagy and tumour suppressor
activity. Nat Cell Biol. 12:665–675. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang J, Ng S, Wang J, Zhou J, Tan SH,
Yang N, Lin Q, Xia D and Shen HM: Histone deacetylase inhibitors
induce autophagy through FOXO1-dependent pathways. Autophagy.
11:629–642. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Rehman A, Kim Y, Kim H, Sim J, Ahn H,
Chung MS, Shin SJ and Jang K: FOXO3a expression is associated with
lymph node metastasis and poor disease-free survival in
triple-negative breast cancer. J Clin Pathol. 71:806–813. 2018.
View Article : Google Scholar : PubMed/NCBI
|
